Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non–muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial
Anirban P. Mitra(The University of Texas MD Anderson Cancer Center), Colin P. Dinney(The University of Texas MD Anderson Cancer Center), Michael A. O’Donnell(University of Iowa Health Care), Thomas J. Guzzo(Hospital of the University of Pennsylvania), Daniel Canter(Ochsner Medical Center), Paul L. Crispen(University of Kentucky), Gennady Bratslavsky(SUNY Upstate Medical University), Tracy M. Downs(University of Wisconsin–Madison), Tanner Miest(The University of Texas MD Anderson Cancer Center), Alan Boyd(University of Edinburgh), Seppo Ylä‐Herttuala(University of Eastern Finland), Robert S. Svatek(The University of Texas at San Antonio Health Science Center), Brian R. Lane(Grand Rapids Community College), Michael B. Williams(Eastern Virginia Medical School), Lawrence I. Karsh(The Urology Center of Colorado), Joseph Mashni(The University of Texas MD Anderson Cancer Center), Sharada Mokkapati(The University of Texas MD Anderson Cancer Center), Adam Luchey(West Virginia University), Ashish M. Kamat(The University of Texas MD Anderson Cancer Center), Yair Lotan(Southwestern Medical Center), Nigel Parker(University of Eastern Finland), Tracey L. Krupski(University of Virginia Cancer Center), Seth P. Lerner(Baylor College of Medicine), Brant A. Inman(Duke Medical Center), Michael S. Cookson(University of Oklahoma Health Sciences Center), Gary D. Steinberg(Rush University Medical Center), David J. McConkey(Johns Hopkins University), Gordon Brown(New Jersey Urology), Badrinath R. Konety(Allina Health), Anne Schuckman(University of Southern California), Vikram M. Narayan(Emory University), Michael Woods(University of Cambridge), Leonard G. Gomella(Thomas Jefferson University), Trinity J. Bivalacqua(University of Pennsylvania), Stephen A. Boorjian(Mayo Clinic), Gerald L. Andriole(Institut thématique Génétique, génomique et bioinformatique), Michael Poch(Moffitt Cancer Center), Neal D. Shore(Carolina Urologic Research Center), Kirk A. Keegan(Vanderbilt University Medical Center), J. Erik Busby(University of Alabama at Birmingham), Alexander I. Sankin(Montefiore Medical Center), Jeffrey S. Montgomery(Ann Arbor Center for Independent Living), Richard Philipson(Parker Hannifin (United Kingdom)), Mehrdad Alemozaffar(Kaiser Permanente), David G. Sawutz
Cited by 24
Related Papers
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
|New England Journal of Medicine|2005|3.1k
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k
Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.
|Journal of Clinical Investigation|1989|1.9k